FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Professur für Innere Medizin (Nephrologie und Hypertensiologie)
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Department of Medicine 4 – Nephrology and Hypertension
Lehrstuhl für Innere Medizin IV
Overview
Publications
(65)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (2016)
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann J, Nauck MA, Nissen SE, et al.
Journal article
Population-Attributable Fractions of Modifiable Lifestyle Factors for CKD and Mortality in Individuals With Type 2 Diabetes: A Cohort Study (2016)
Dunkler D, Kohl M, Teo KK, Heinze G, Dehghan M, Clase CM, Gao P, et al.
Journal article
Diet and Major Renal Outcomes: A Prospective Cohort Study. The NIH-AARP Diet and Health Study (2016)
Smyth A, Griffin M, Yusuf S, Mann J, Reddan D, Canavan M, Newell J, O'Donnell M
Journal article
Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies (2016)
Mente A, O'Donnell M, Rangarajan S, Dagenais G, Lear S, McQueen M, Diaz R, et al.
Journal article
LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial (2016)
Petrie JR, Marso SP, Bain SC, Franek E, Jacob S, Masmiquel L, Leiter LA, et al.
Journal article
Genome-wide studies to identify risk factors for kidney disease with a focus on patients with diabetes (2015)
Regele F, Jelencsics K, Shiffman D, Pare G, Mcqueen MJ, Mann J, Oberbauer R
Journal article
LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations (2015)
Daniels GH, Hegedus L, Marso SP, Nauck MA, Zinman B, Bergenstal RM, Mann J, et al.
Journal article
Risk Prediction for Early CKD in Type 2 Diabetes (2015)
Dunkler D, Gao P, Lee SF, Heinze G, Clase CM, Tobe S, Teo KK, et al.
Journal article
Intraprocedural reduction of the veno-arterial norepinephrine gradient correlates with blood pressure response after renal denervation (2015)
Tiroch K, Sause A, Szymanski J, Nover I, Leischik R, Mann J, Vorpahl M, Seyfarth M
Journal article
Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study) (2015)
Gesualdo L, Combe C, Covic A, Dellanna F, Goldsmith D, London G, Mann J, et al.
Journal article
‹
1
...
3
4
5
6
7
›